Document Detail

Myocardial preservation in neonatal lambs. Comparison of hypothermia with crystalloid and blood cardioplegia.
MedLine Citation:
PMID:  2008109     Owner:  NLM     Status:  MEDLINE    
Low cardiac output after surgically induced myocardial ischemia is a major contributor to mortality and morbidity after operations for congenital heart defects, despite myocardial "protection" with the techniques of hypothermia and cardioplegia that have been effective in protecting mature myocardium. The purpose of this study was to investigate the effectiveness of topical cooling to 15 degrees C, crystalloid cardioplegia, and blood cardioplegia in protecting 28 isolated neonatal lamb hearts subjected to 2 hours of ischemia. Seven hearts were isolated and perfused in a similar manner with cooling to 15 degrees C but were then rewarmed without any ischemia to serve as a control group. All three groups (topical cooling, crystalloid cardioplegia, and blood cardioplegia) had recovery of systolic function (as measured by maximum developed pressure, maximum rate of pressure rise, peak developed pressure at a fixed volume, and peak rate of pressure rise at a fixed volume) equal to the control group; the exception was peak rate of pressure rise at a fixed volume in the blood cardioplegia group, in which recovery was worse than in the control group. No differences among three ischemia groups or in comparison with the control group were found for measures of diastolic function (ventricular diastolic pressure at a fixed volume or stiffness constant kA). Systolic function declined in all groups (including control) from baseline to the end of the experiment. These findings suggest that hypothermia exerted the dominant protective effect in these normal neonatal lamb hearts and there was no added protection from either crystalloid or blood cardioplegia.
T Fujiwara; J Heinle; L Britton; J E Mayer
Related Documents :
2470359 - Significance of the cardioprotective effect of prostanoids and indomethacin.
11323529 - Relation of apparent diffusion coefficient changes and metabolic disturbances after 1 h...
22595449 - The evolving role of β-adrenergic receptor blockers in managing hypertension.
9698529 - Decreased expression of tissue inhibitor of metalloproteinase 1 in stunned myocardium.
1559939 - Injury in nonischemic lung after unilateral pulmonary ischemia with reperfusion.
7509989 - Differential effects of endothelin-1 on normal and postischemic reperfused myocardium.
7524359 - Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism.
14769749 - Pulmonary responses to selective phosphodiesterase-5 and phosphodiesterase-3 inhibitors.
435589 - Comparison of cardiovascular reflexes of the newborn and adult opossum.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  101     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1991 Apr 
Date Detail:
Created Date:  1991-05-01     Completed Date:  1991-05-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  703-12     Citation Subset:  AIM; IM    
Department of Surgery, Children's Hospital, Boston, Mass. 02115.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Animals, Newborn
Body Water / metabolism
Cardioplegic Solutions*
Coronary Circulation
Heart / physiopathology*
Hypothermia, Induced*
Isotonic Solutions
Myocardial Contraction
Myocardium / metabolism
Oxygen Consumption
Plasma Substitutes*
Reg. No./Substance:
0/Cardioplegic Solutions; 0/Isotonic Solutions; 0/Plasma Substitutes; 0/crystalloid solutions

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemi...
Next Document:  A clinical trial of allopurinol (Zyloric) for myocardial protection.